Invacare Corporation

Invacare — UBS Global Healthcare Conference 2021

13 slides from Invacare's conference presentation, May 25, 2021

  1. Slide 1: UBS Global Healthcare Conference

    I N VA C A R E C O R P O R AT I O N UBS Global Healthcare Conference May 25, 2021

  2. Slide 2: Forward Looking Statements

    I N VA C A R E C O R P O R AT I O N Forward Looking Statements This presentation contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expec

  3. Slide 3: Making Life's Experiences Possible

    I N VA C A R E C O R P O R AT I O N Making Life’s Experiences Possible Who We Are What We Do Celebrating over 40 years of Making Life’s Experiences Possible Headquartered near Cleveland, OH Design, manufacture and distribute durable medical equipment for congenital, acquired and degenerative conditi

  4. Slide 4: Broad Product Line with High Clinical Value

    Reported Net Sales * Broad Product Line with High Clinical Value I N VA C A R E C O R P O R AT I O N $450 $828 $395 $400 Million* Lifestyles (Rest & Hygiene) $350 Globally focused on home healthcare and post-acute care, $307 including aids for daily living, walking aids, lifts, wheelchairs, $300 bed

  5. Slide 5: Initiatives Accelerating Our Business Optimization Strategy

    I N VA C A R E C O R P O R AT I O N Initiatives Accelerating Our Business Optimization Strategy Award winning clinical solutions and full product pipeline: ✓ Launched center-wheel, front-wheel, and rear-wheel drive standing positioning system with clinical and social benefits of vertical positioning

  6. Slide 6: Innovation Pipeline

    Innovation Pipeline Mobility & Seating Supporting sales growth with frequent introduction of clinically innovative solutions Lifestyle Respiratory I N VA C A R E C O R P O R AT I O N Jan Ampla bariatric manual chair May Mar Jul SMOOV AVIVA® FX / Clematis Pro One™ Power AVIVA RX tilt-in-space May Add

  7. Slide 7: Culture of Innovation & Process Improvements Paves Way for Growth

    Culture of Innovation & Process Improvements Paves Way for Growth I N VA C A R E C O R P O R AT I O N Product introductions in all categories to drive incremental sales at higher margins Business Optimization ✓ Completed the outsourcing of the IT infrastructure and began deploying our modernized IT

  8. Slide 8: Demonstrated Improvement in Financial Performance

    I N VA C A R E C O R P O R AT I O N Demonstrated Improvement in Financial Performance % of Net Sales Operating Income (Loss) 29.5% 29.0% 28.8% 29.0% ($18.3) 2018 28.5% 28.2% 28.0% ($10.4) 2019 27.5% 28.0% 27.5% 27.8% 27.0% 2020 2020* $11.3 26.5% 2018 2019 2020 ($20.0) ($15.0) ($10.0) ($5.0) $0.0 $5.

  9. Slide 9: Balance Sheet Supports Strategic Growth Plans

    Balance Sheet Supports Strategic Growth Plans As of March 31, 2021 I N VA C A R E C O R P O R AT I O N Total Debt * Cash Total Debt of $298 million comprised of: Cash of $86 million: In 1Q21, the company issued $125 million - $278 million in convertible debt - Decreased due to cash used in operation

  10. Slide 10: Positive Trends Expected to Drive Growth in the Second Half

    I N VA C A R E C O R P O R AT I O N Positive Trends Expected to Drive Growth in the Second Half As global supply chain issues abate and key markets re-open, we expect a strong second half driven by: • Fulfillment of elevated backlog from 1Q21 to historical levels • Strong sequential trends and impro

  11. Slide 11: Full Year 2021 Guidance

    Full Year 2021 Guidance As reported on May 5, 2021 I N VA C A R E C O R P O R AT I O N Based on expectations of continued progress of the company's performance, increased visibility into the path of recovery for its customers, expected improvements to healthcare Adjusted EBITDA (in millions) access,

  12. Slide 12: Business Improvement Highlights

    I N VA C A R E C O R P O R AT I O N Business Improvement Highlights We are transforming to regain market leadership We have a clear roadmap to further enhance and simplify our operations Key Takeaways We have a strong pipeline of innovative products coming to market Our financial performance is impr

  13. Slide 13: Thank You Q&A

    I N VA C A R E C O R P O R AT I O N Thank You Q&A Invacare Corporation Presentation – May 25, 2021

Invacare — UBS Global Healthcare Conference 2021 on 6ix